NCT04963881View on ClinicalTrials.gov

Antiphospholipid Antibodies in Patients of Antiphospholipid Syndrome (APS) With Systemic Lupus Erythematosus (SLE).

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

October 10, 2019

Primary Completion Date

January 1, 2021

Study Completion Date

January 1, 2021

Conditions

Anti-phospholipid Antibobodies in Patients of SLE Presenting With Thrombosis or Pregnancy Complications

Interventions

DIAGNOSTIC_TEST

Antibody testing

Blood samples were taken and analyzed for APS antibodies

Trial Locations (1)

7200

Fatima Memorial Hospital, Lahore

All Listed Sponsors

lead

Fatima Memorial Hospital

OTHER

NCT04963881 - Antiphospholipid Antibodies in Patients of Antiphospholipid Syndrome (APS) With Systemic Lupus Erythematosus (SLE). | Biotech Hunter | Biotech Hunter